J0275
HCPCSAlprostadil urethral suppos
Official HCPCS Level II long descriptor
Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
HCPCS Level II code J0275 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Alprostadil urethral suppos
Added to HCPCS: 1999-01-01
Nearby codes in J0
- J0222Inj., patisiran, 0.1 mg
- J0223Inj givosiran 0.5 mg
- J0224Inj. lumasiran, 0.5 mg
- J0225Inj, vutrisiran, 1 mg
- J0248Inj, remdesivir, 1 mg
- J0256Alpha 1 proteinase inhibitor
- J0257Glassia injection
- J0270Alprostadil for injection
- J0278Amikacin sulfate injection
- J0280Aminophyllin 250 mg inj
- J0281Inj aminocaproic acid 1 gram
- J0282Amiodarone hcl
- J0283Inj, amiodarone (nexterone)
- J0285Amphotericin b
- J0287Amphotericin b lipid complex
- J0289Amphotericin b liposome inj
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.